First-line Therapy in Metastatic PDAC
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
- Status
- COMPLETED
- Phase
- PHASE3
Divestment for Artery-involved Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- Status
- RECRUITING
- Phase
- PHASE3